{
    "2020-07-23": [
        [
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)委任楼柏良、楼小强及郑北为执行董事",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "执行董事",
                        "楼柏良",
                        "楼小强",
                        "郑北"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【A股收盘综述】上证指数探底回升收跌0.24%，机构抱团股涨势依旧如火如荼",
                "features": {
                    "keywords": [
                        "A股",
                        "上证指数",
                        "探底回升",
                        "机构抱团股"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|点评】昭衍新药拟H股上市，岸外包业务的必然选择",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "H股上市",
                        "外包业务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物、智飞生物、康龙化成均创新高，复星医药大涨超6%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "智飞生物",
                        "康龙化成",
                        "复星医药",
                        "创新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|外包周报】A+H加速布局下医药CXO板块，是否还可以加仓？",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "外包周报",
                        "A+H布局",
                        "CXO板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】持续关注Q2基金重仓提升的制药创新产业链─医药行业周报",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "周报",
                        "Q2基金重仓",
                        "制药创新产业链"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}